Baxter Phillips
Chief Operating Officer at LOBE SCIENCES LTD.
Net worth: 11 560 $ as of 2024-05-30
Baxter Phillips active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LOBE SCIENCES LTD. | Director/Board Member | 2022-10-02 | - |
| Chief Operating Officer | 2023-06-06 | - | |
Cambridge Allergy Ltd.
 Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2018-10-15 | - |
| Independent Dir/Board Member | - | - | |
| Chief Executive Officer | 2018-10-15 | - | |
Altemia & Co. LLC
 Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Part of Clearway Global LLC, Altemia & Co. LLC is a medical food company. The company is based in Stuart, FL. Altemia & Co. was acquired by Lobe Sciences Ltd. on April 29, 2024 for $1.01 million. | President | - | - |
Career history of Baxter Phillips
Former positions of Baxter Phillips
| Companies | Position | Start | End |
|---|---|---|---|
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Chief Executive Officer | 2015-09-30 | 2017-09-30 |
| President | 2015-09-30 | 2017-09-30 | |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Investor Relations Contact | 2013-11-12 | 2015-05-26 |
| Corporate Officer/Principal | 2013-11-12 | 2015-09-30 | |
| OSTEOLOGIX HOLDINGS PLC | Public Communications Contact | 2010-05-05 | 2011-07-31 |
| Corporate Officer/Principal | 2007-05-31 | 2010-05-05 |
Training of Baxter Phillips
| Hampden-Sydney College | Undergraduate Degree |
| Mason School of Business of The College of William & Mary | Masters Business Admin |
Statistics
International
| United States | 6 |
| Ireland | 2 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| LOBE SCIENCES LTD. | Process Industries |
| Private companies | 5 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Part of Clearway Global LLC, Altemia & Co. LLC is a medical food company. The company is based in Stuart, FL. Altemia & Co. was acquired by Lobe Sciences Ltd. on April 29, 2024 for $1.01 million. | Health Technology |
- Stock Market
- Insiders
- Baxter Phillips
- Experience
